For too long, regulatory teams have become bogged down by protracted reviews of the regulatory implications. Generative AI (GenAI) promises to change all that, say independent consultant Preeya Beczek and Agnes Cwienczek of ArisGlobal.
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a Gold Winner in the 2025 Merit Awards for Business in the Research and Development category.
Shift Bioscience (Shift), a company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the results of a study detailing an improved approach to ranking virtual cell models for gene discovery.
OutSee has announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.
Antares Vision Group in collaboration with Oròbix has introduced AI-GO, an artificial intelligence-driven visual inspection platform that elevates standards across several key performance indicators.
Updesh Dosanjh, practice leader, Pharmacovigilance Technology Solutions, IQVIA explains how Artificial intelligence (AI) is now deeply embedded in pharmaceutical operations, especially in pharmacovigilance.
Median Technologies will be participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from 30th May - 2nd June, McCormick Place, Chicago, IL, USA.
Process industry software specialist, eschbach, has won the German Innovation Award for its use of artificial intelligence (AI) to drive productivity and efficiency in the chemical and pharmaceutical industries.
Domino Data Lab, provider of the Enterprise AI platform, has announced continued life sciences traction and new capabilities to bridge a critical industry gap.
Qubit Pharmaceuticals, a deeptech company specialising in the discovery of new drug candidates, unveils the "world’s most advanced" quantum AI model to unlock an entirely new range of therapeutics.
